Loading provider…
Loading provider…
Internal Medicine Physician in Detroit, MI
NPI: 1366510810Primary Practice Location
HENRY FORD HEALTH HOSPITAL
2799 W Grand Blvd, Detroit, MI
Primary Employer
Henry Ford Health
henryford.com
HQ Phone
Get M.D. Philip's Phone Numberphone_androidMobile
Get M.D. Philip's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMI State Medical License
2002 - 2027
FL State Medical License
1998 - 2016
MI State Medical License

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology
Henry Ford Health/Henry Ford Hospital
Residency • Internal Medicine
1996 - 1999
Christian Medical College Ludhiana
Medical School
Until 1990
Mayo Clinic Alix School of Medicine - Rochester
college.mayo.edu
Fellowship • Hematology and Medical Oncology
1999 - 2002
Chemotherapy as Treatment for Acute Myeloid Leukemia (AML)-Induced Facial Nerve Palsy.
Authors: Fana, Michael, Centofanti, Brook, Kuriakose, Philip
Journal: Cureus
Publication Date: 2022-03-31
Authors: Thomson, Julie, Kuriakose, Philip, To, Long, Peters, Michael, Kalus, James
Journal: J Thromb Thrombolysis
Impact of a Pharmacist-Directed Anticoagulation Service on the Quality and Safety of Heparin-Induced Thrombocytopenia Management
Authors: Long To, Jessica Schillig, Brian D. Desmet, Philip Kuriakose, Edward G. Szandzik, James S. Kalus
Publication Date: 2011-02
Lead Sponsor: American Thrombosis and Hemostasis Network
Collaborators: LFB USA, Inc.
Intervention / Treatment: DRUG: coagulation factor VIIa [recombinant]-jncw
Lead Sponsor: Baxalta now part of Shire
Collaborators: Baxalta Innovations GmbH, now part of Shire
Intervention / Treatment: BIOLOGICAL: OBIZUR
Lead Sponsor: Cyclacel Pharmaceuticals, Inc.
Intervention / Treatment: DRUG: Decitabine, DRUG: Sapacitabine